![]() |
|
![]() |
|
Systematic (IUPAC) name | |
---|---|
3-[5-(4-Chlorophenyl)-1-(4-methoxyphenyl)pyrazol-3-yl]-N-hydroxy-N-methylpropanamide
|
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Routes of administration |
Oral |
Legal status | |
Legal status |
|
Identifiers | |
ATCvet code | QM01AE92 (WHO) |
PubChem | CID 59757 |
ChemSpider | 53906 |
UNII | TZ4OX61974 ![]() |
KEGG | D06075 ![]() |
ChEBI | CHEBI:76277 ![]() |
Chemical data | |
Formula | C20H20ClN3O3 |
Molar mass | 385.844 g/mol |
|
|
|
|
![]() ![]() |
Tepoxalin is a nonsteroidal anti-inflammatory drug approved for veterinary use in the United States and many other countries.[1] It is primarily used to reduce inflammation and relief of pain caused by musculoskeletal disorders such as hip dysplasia and arthritis.[2]
It is generally marketed under the brand name Zubrin.[1]
See also
References
|